Back to Search
ADRIAN SENDEROWICZ, MD
MD
Medical Oncology Physician
NPI: 1396935649Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
189465-1(NY)
Research & Publications (20)
Inhibitors of cyclin-dependent kinase modulators for cancer therapy.
PMID 16265881·Prog Drug Res·2005
6-review
Targeting cell cycle and apoptosis for the treatment of human malignancies.
PMID 15530779·Curr Opin Cell Biol·2004
6-review
Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms.
PMID 12819936·Cancer Chemother Pharmacol·2003
6-review
Cell cycle modulators for the treatment of lung malignancies.
PMID 14667271·Clin Lung Cancer·2003
6-review
Role of cell cycle control and cyclin-dependent kinases in breast cancer.
PMID 15687644·Breast Dis·2002
8-other
The cell cycle as a target for cancer therapy: basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01.
PMID 12165651·Oncologist·2002
6-review
Cyclin-dependent kinases as new targets for the prevention and treatment of cancer.
PMID 12512390·Hematol Oncol Clin North Am·2002
6-review
Cyclin-dependent kinases as targets for cancer therapy.
PMID 12703205·Cancer Chemother Biol Response Modif·2002
6-review
Cyclin-dependent kinase modulators: a novel class of cell cycle regulators for cancer therapy.
PMID 11686013·Cancer Chemother Biol Response Modif·2001
6-review
Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies.
PMID 11243375·Leukemia·2001
6-review
Preclinical and clinical development of cyclin-dependent kinase modulators.
PMID 10699068·J Natl Cancer Inst·2000
6-review
Small molecule modulators of cyclin-dependent kinases for cancer therapy.
PMID 11426645·Oncogene·2000
6-review
Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).
PMID 18942117·Mol Carcinog·2009
7-preclinical
S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cells.
PMID 18162471·J Biol Chem·2008
8-other
Expression of CDK4 or CDK2 in mouse oral cavity is retained in adult pituitary with distinct effects on tumorigenesis.
PMID 18172308·Cancer Res·2008
7-preclinical
CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development.
PMID 18599613·Am J Pathol·2008
7-preclinical
Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas.
PMID 18247017·Oncology (Williston Park)·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9406 LINDEN AVE
BETHESDA, MD 20814 - Phone
- (301) 530-0892
Quick Facts
- NPI
- 1396935649
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile